Menu
Recruiting NCT06979804

A Comparison of Outcomes After Anterior Cruciate Ligament (ACL) or Anterior Cruciate Ligament and Meniscus (ACL+Meniscus) Surgery Using Semiconductor Fabric Products

No phase Interventional ACL Reconstruction Meniscus Tears Anterior Cruciate Ligament Rupture

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Semiconducting fabric sleeves, Non-semiconducting fabric sleeves.
Who it may be relevant to
Registry conditions: ACL Reconstruction, Meniscus Tears, Anterior Cruciate Ligament Rupture. Basic parameters: 16 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

A Comparison of Outcomes After Anterior Cruciate Ligament (ACL) or Anterior Cruciate Ligament and Meniscus (ACL+Meniscus) Surgery Using Semiconductor Fabric Products: A Randomized, Double-Blinded, Placebo-Controlled Prospective Clinical Study

Overview

The goal of this clinical trial is to determine the effect of semiconductor sleeves on the treatment of Anterior Cruciate Ligament (ACL) or Anterior Cruciate Ligament and Meniscus (ACL+Meniscus) arthroscopic surgery. The effect of the sleeves will be analyzed through patient reported and clinically measured outcomes. The main questions it aims to answer are: * Do the semiconductor sleeves improve the functional outcomes compared to the placebo? * Will patients experience improved functional outcomes in a shorter period of time compared to the placebo? Researchers will compare semiconductor fabric sleeves to a placebo (a look-alike sleeve that contains no semiconductor material) to see if the semiconductor fabric better treats ACL and ACL+meniscus surgical patients. Participants will: * Wear semiconductor or placebo leg sleeve for 4 weeks and knee sleeve for the following 12 weeks * Complete patient reported outcome surveys

Interventions

  • Device Semiconducting fabric sleeves
    This intervention includes semiconductor embedded sleeves that patients will wear for 4 months post-operatively.
  • Device Non-semiconducting fabric sleeves
    This intervention includes sleeves absent of semiconductors that will be worn for 4 months post-operatively.

Primary outcome measures

  • Range of motion [Time frame: 1 year]
Secondary outcome measures (7)
  • Effusion Measurements [Time frame: 1 year]
  • Secondary Outcome Measures using Validated patient-reported outcome tools questionnaires [Time frame: 1 year]
  • Secondary Outcome Measures using Validated patient-reported outcome tools questionnaires [Time frame: 1 year]
  • Secondary Outcome Measures using Validated patient-reported outcome tools questionnaires [Time frame: 1 year]
  • Secondary Outcome Measures using Validated patient-reported outcome tools questionnaires [Time frame: 1 year]
  • Secondary Outcome Measures using Validated patient-reported outcome tools questionnaires [Time frame: 1 year]
  • Secondary Outcome Measures using Validated patient-reported outcome tools questionnaires [Time frame: 1 year]

Eligibility criteria

Inclusion criteria

  • Patients undergoing ACL or ACL+Meniscus surgery
  • Age 16 - 65
  • Patients with Body Mass Index (BMI) <40
  • Patients who are willing and able to adhere to follow-up schedule and protocol guidelines.
  • Patients who are willing and able to sign corresponding research subject consent/assent form.

Exclusion criteria

  • Patient has a history of neurological conditions, including multiple sclerosis or Parkinson's disease
  • Patient has severe medical condition, including recent myocardial infarction, unstable angina, heart failure, severe anemia
  • Patient has had prior surgical treatment of the knee in the last 5 years or injection treatment(s) in the last 6 months
  • Patient has chronic pain conditions unrelated to knee condition
  • Patient has auto-immune or auto-inflammatory diseases
  • Patient has poorly controlled diabetes (HgA1c > 7.5)
  • Patient has BMI > 39.9
  • Patient has varicosities on the operative leg
  • Patient has severe peripheral artery disease (ABI < 0.6)
  • Patient is considered a pain management patient
  • Patient has had previous blood clots or stroke
  • Patient has used tobacco within the last 90 days
  • Patient is not within the ages of 16-65
  • Patient has an active infection (local or systemic), or an open (non-surgical) wound in the areas of product application
  • Patient is unwilling or unable to sign the corresponding research subject consent/assent form
  • Patient meets any other criteria or has any other condition that, in the opinion of the investigator, would prevent them from completing the study or that, in the opinion of the investigator, would confound study results.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Triple blind
Primary purpose
Treatment

Study locations

United States · 1 center
  • Illinois Bone and Joint Institute — Westmont

Publications

  • O'Riordan SF, Bishop DJ, Halson SL, Broatch JR. Do Sports Compression Garments Alter Measures of Peripheral Blood Flow? A Systematic Review with Meta-Analysis. Sports Med. 2023 Feb;53(2):481-501. doi: 10.1007/s40279-022-01774-0. Epub 2023 Jan 9. PMID 36622554
  • Leung TK. In Vitro and In Vivo Studies of the Biological Effects of Bioceramic (a Material of Emitting High Performance Far-Infrared Ray) Irradiation. Chin J Physiol. 2015 Jun 30;58(3):147-55. doi: 10.4077/CJP.2015.BAD294. PMID 26014120
  • Justice TE, Jacob PB. Non-compressive sleeves versus compression stockings after total knee arthroplasty: A prospective pilot study. J Orthop. 2023 Nov 24;49:102-106. doi: 10.1016/j.jor.2023.11.044. eCollection 2024 Mar. PMID 38094981

Identifiers

NCT: NCT06979804 · 12178

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗